creatine has been researched along with Critical Illness in 18 studies
Critical Illness: A disease or state in which death is possible or imminent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This prospective, open-label, clinical trial was conducted to describe the pharmacology of bumetanide in pediatric patients with edema." | 5.08 | Pharmacokinetics and pharmacodynamics of bumetanide in critically ill pediatric patients. ( Kearns, GL; Letzig, L; Marshall, JD; Wells, TG, 1998) |
| " The predefined PK/pharmacodynamic (PK/PD) target was 100% fT>4MIC [percentage of time during a dosing interval that the free (f) drug concentration exceeded 4 times the MIC]." | 2.79 | Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: a randomised controlled trial. ( Boelens, J; Carlier, M; Carrette, S; Claeys, G; De Waele, JJ; Decruyenaere, J; Depuydt, P; Hoste, E; Leroux-Roels, I; Stove, V; Verstraete, AG, 2014) |
| "Sepsis was defined clinically." | 2.75 | Urinary cystatin C is diagnostic of acute kidney injury and sepsis, and predicts mortality in the intensive care unit. ( Endre, ZH; Frampton, CM; Nejat, M; Pickering, JW; Shaw, GM; Walker, RJ; Westhuyzen, J, 2010) |
| "Muscle wasting during critical illness impairs recovery." | 2.52 | Impact of supplementation with amino acids or their metabolites on muscle wasting in patients with critical illness or other muscle wasting illness: a systematic review. ( Brett, SJ; Frost, G; Hickson, M; Wandrag, L, 2015) |
| " The present contribution discusses the principles of drug dosing during CVVH and compares the various proposed dosing strategies." | 2.44 | Antimicrobial dosing strategies in critically ill patients with acute kidney injury and high-dose continuous veno-venous hemofiltration. ( Bouman, CS, 2008) |
| " An early switch from intravenous to enteral moxifloxacin may be considered because of its good oral bioavailability in healthy volunteers." | 1.38 | Switch from intravenous to enteral moxifloxacin in critically ill patients: a pilot study. ( Boussery, K; Colpaert, K; de Paepe, P; de Smet, J; Decruyenaere, J; van Bocxlaer, J, 2012) |
| "Oliguria was defined by a urine output < 0." | 1.37 | Oliguria as predictive biomarker of acute kidney injury in critically ill patients. ( Bagshaw, SM; Bellomo, R; Cruz, D; Egi, M; Haase, M; Haase-Fielitz, A; Kellum, JA; Licari, E; Liu, YL; Prowle, JR; Ronco, C; Tsutsui, K; Uchino, S, 2011) |
| "The data of 199 consecutive cancer patients treated with C-SLED were analyzed." | 1.35 | Sustained low efficiency dialysis in the continuous mode (C-SLED): dialysis efficacy, clinical outcomes, and survival predictors in critically ill cancer patients. ( Kumar, V; Lahoti, A; Madan, N; Nates, J; Price, K; Salahudeen, AK; Samuels, J; Xiao, L, 2009) |
| "Measurement of renal function is important to optimize drug dosing in critically ill pediatric patients and to prevent dose-related toxicities caused by medications that are eliminated or metabolized by the kidney." | 1.33 | 12-hour versus 24-hour creatinine clearance in critically ill pediatric patients. ( Abdolell, M; Harvey, E; Herridge, J; Kavanagh, BP; Pong, S; Seto, W; Trope, A; Wong, K, 2005) |
| " Exclusion criteria were: age <18 years, impaired renal function (24-hour creatinine clearance <90 ml/min) or previous adverse reaction to either drug." | 1.33 | Nephrotoxicity due to combination antibiotic therapy with vancomycin and aminoglycosides in septic critically ill patients. ( Bergamasco, S; Donadio, C; Malacarne, P, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (16.67) | 18.2507 |
| 2000's | 7 (38.89) | 29.6817 |
| 2010's | 7 (38.89) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Gala, K | 1 |
| Desai, V | 1 |
| Liu, N | 1 |
| Omer, EM | 1 |
| McClave, SA | 1 |
| Ataei, N | 1 |
| Bazargani, B | 1 |
| Ameli, S | 1 |
| Madani, A | 1 |
| Javadilarijani, F | 1 |
| Moghtaderi, M | 1 |
| Abbasi, A | 1 |
| Shams, S | 1 |
| Ataei, F | 1 |
| De Waele, JJ | 1 |
| Carrette, S | 1 |
| Carlier, M | 1 |
| Stove, V | 1 |
| Boelens, J | 1 |
| Claeys, G | 1 |
| Leroux-Roels, I | 1 |
| Hoste, E | 1 |
| Depuydt, P | 1 |
| Decruyenaere, J | 2 |
| Verstraete, AG | 1 |
| Wandrag, L | 1 |
| Brett, SJ | 1 |
| Frost, G | 1 |
| Hickson, M | 1 |
| Bouman, CS | 1 |
| Salahudeen, AK | 1 |
| Kumar, V | 1 |
| Madan, N | 1 |
| Xiao, L | 1 |
| Lahoti, A | 1 |
| Samuels, J | 1 |
| Nates, J | 1 |
| Price, K | 1 |
| Weitzel, LR | 1 |
| Sandoval, PA | 1 |
| Mayles, WJ | 1 |
| Wischmeyer, PE | 1 |
| Nejat, M | 1 |
| Pickering, JW | 1 |
| Walker, RJ | 1 |
| Westhuyzen, J | 1 |
| Shaw, GM | 1 |
| Frampton, CM | 1 |
| Endre, ZH | 1 |
| Rödl, S | 1 |
| Marschitz, I | 1 |
| Mache, CJ | 1 |
| Koestenberger, M | 1 |
| Madler, G | 1 |
| Rehak, T | 1 |
| Zobel, G | 1 |
| Prowle, JR | 1 |
| Liu, YL | 1 |
| Licari, E | 1 |
| Bagshaw, SM | 1 |
| Egi, M | 1 |
| Haase, M | 1 |
| Haase-Fielitz, A | 1 |
| Kellum, JA | 1 |
| Cruz, D | 1 |
| Ronco, C | 1 |
| Tsutsui, K | 1 |
| Uchino, S | 1 |
| Bellomo, R | 1 |
| de Smet, J | 1 |
| Colpaert, K | 1 |
| de Paepe, P | 1 |
| van Bocxlaer, J | 1 |
| Boussery, K | 1 |
| Pong, S | 1 |
| Seto, W | 1 |
| Abdolell, M | 1 |
| Trope, A | 1 |
| Wong, K | 1 |
| Herridge, J | 1 |
| Harvey, E | 1 |
| Kavanagh, BP | 1 |
| Cutinha, D | 1 |
| Vaja, S | 1 |
| Treacher, D | 1 |
| Swaminathan, R | 1 |
| Malacarne, P | 1 |
| Bergamasco, S | 1 |
| Donadio, C | 1 |
| Herrera-Gutiérrez, ME | 1 |
| Seller-Pérez, G | 1 |
| Banderas-Bravo, E | 1 |
| Muñoz-Bono, J | 1 |
| Lebrón-Gallardo, M | 1 |
| Fernandez-Ortega, JF | 1 |
| Rooyackers, OE | 1 |
| Gijsen, AP | 1 |
| Saris, WH | 1 |
| Soeters, PB | 1 |
| Wagenmakers, AJ | 1 |
| Marshall, JD | 1 |
| Wells, TG | 1 |
| Letzig, L | 1 |
| Kearns, GL | 1 |
| Dehne, MG | 1 |
| Mühling, J | 1 |
| Papke, G | 1 |
| Nopens, H | 1 |
| Kuntzsch, U | 1 |
| Hempelmann, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prospective Observational Study of Serum Ceftazidime Concentrations in Hemodialysis Patients at the University Hospital of Charleroi, Belgium[NCT03634904] | 20 participants (Anticipated) | Interventional | 2018-09-15 | Not yet recruiting | |||
| Effect of a Power/Resistance Exercise Program and Oral Supplementation With Beta-hydroxy-beta-methyl Butyrate (HMB) on the Muscle Quality Index in Older Adults. A Randomized Controlled Trial[NCT04734951] | 76 participants (Anticipated) | Interventional | 2023-06-30 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for creatine and Critical Illness
| Article | Year |
|---|---|
How to Increase Muscle Mass in Critically Ill Patients: Lessons Learned from Athletes and Bodybuilders.
Topics: Athletes; Creatine; Critical Illness; Dietary Supplements; Eating; Exercise; Hospitalization; Humans | 2020 |
Impact of supplementation with amino acids or their metabolites on muscle wasting in patients with critical illness or other muscle wasting illness: a systematic review.
Topics: Aged; Amino Acids; Amino Acids, Essential; Body Composition; Creatine; Critical Illness; Diet; Dieta | 2015 |
Antimicrobial dosing strategies in critically ill patients with acute kidney injury and high-dose continuous veno-venous hemofiltration.
Topics: Acute Kidney Injury; Anti-Infective Agents; Creatine; Critical Illness; Drug Monitoring; Hemofiltrat | 2008 |
Performance-enhancing sports supplements: role in critical care.
Topics: Amino Acids, Branched-Chain; Anabolic Agents; Androgens; Arginine; Creatine; Critical Care; Critical | 2009 |
3 trials available for creatine and Critical Illness
| Article | Year |
|---|---|
Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: a randomised controlled trial.
Topics: beta-Lactamase Inhibitors; Creatine; Critical Illness; Dose-Response Relationship, Drug; Drug Monito | 2014 |
Urinary cystatin C is diagnostic of acute kidney injury and sepsis, and predicts mortality in the intensive care unit.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Area Under Curve; Australia; Creatine; Critical | 2010 |
Pharmacokinetics and pharmacodynamics of bumetanide in critically ill pediatric patients.
Topics: Adult; Alkalosis; Area Under Curve; Bumetanide; Child; Child, Preschool; Chlorides; Creatine; Critic | 1998 |
11 other studies available for creatine and Critical Illness
| Article | Year |
|---|---|
Early detection of acute kidney injury by serum cystatin C in critically ill children.
Topics: Acute Kidney Injury; Area Under Curve; Biomarkers; Child, Preschool; Creatine; Critical Illness; Cys | 2014 |
Sustained low efficiency dialysis in the continuous mode (C-SLED): dialysis efficacy, clinical outcomes, and survival predictors in critically ill cancer patients.
Topics: Acute Kidney Injury; Adult; Aged; Biomarkers; Blood Pressure; Blood Urea Nitrogen; Creatine; Critica | 2009 |
One-year safe use of the Prismaflex HF20(®) disposable set in infants in 220 renal replacement treatment sessions.
Topics: Child, Preschool; Creatine; Critical Illness; Disposable Equipment; Hemodiafiltration; Humans; Infan | 2011 |
Oliguria as predictive biomarker of acute kidney injury in critically ill patients.
Topics: Acute Kidney Injury; Biomarkers; Creatine; Critical Illness; Female; Humans; Intensive Care Units; M | 2011 |
Switch from intravenous to enteral moxifloxacin in critically ill patients: a pilot study.
Topics: Administration, Intravenous; Administration, Oral; Adult; Anti-Infective Agents; Area Under Curve; A | 2012 |
12-hour versus 24-hour creatinine clearance in critically ill pediatric patients.
Topics: Adolescent; Chemistry, Clinical; Child; Child, Preschool; Creatine; Creatinine; Critical Illness; Fe | 2005 |
Erythrocyte zinc content in critically ill patients.
Topics: Acute Disease; Case-Control Studies; Creatine; Critical Illness; Erythrocytes; Humans; Hyperthyroidi | 2005 |
Nephrotoxicity due to combination antibiotic therapy with vancomycin and aminoglycosides in septic critically ill patients.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Creatine; Critical Illness; Drug Therapy, Combin | 2006 |
Replacement of 24-h creatinine clearance by 2-h creatinine clearance in intensive care unit patients: a single-center study.
Topics: Algorithms; Creatine; Critical Care; Critical Illness; Female; Hospitals, University; Humans; Intens | 2007 |
Derangement in aerobic and anaerobic energy metabolism in skeletal muscle of critically ill and recovering rats.
Topics: Adenine Nucleotides; Adenosine Triphosphate; Animals; Creatine; Critical Illness; Energy Metabolism; | 1996 |
Unrecognized renal damage in critically ill patients.
Topics: Acute Kidney Injury; Case-Control Studies; Creatine; Critical Illness; Humans; Kidney; Kidney Functi | 1999 |